Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolates

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3236-3242

  Liao, Robert S ^a   Rennie, Robert P ^a   Talbot, James A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CARBOXYFLUORESCEIN; FLUCONAZOLE; FLUCYTOSINE; FLUORESCENT DYE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ARTICLE; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGUS ISOLATION; INHIBITION KINETICS; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FLUORESCEINS; FLUORESCENT DYES; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECTROPHOTOMETRY;

EID: 0036783697     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3236-3242.2002     Document Type: Article

References (27)

1. Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: An eight-center collaborative study
2. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis
3. Investigational antifungal agents
4. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans
5. Antifungal agents and susceptibility tests
6. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts
7. Assessment of the effect of amphotericin B on the vitality of Candida albicans
8. Novel fluorescent broth microdilution method for fluconazole susceptibility testing of Candida albicans
9. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method
10. The trailing endpoint phenotype in antifungal susceptibility testing is pH dependent
11. The exciting future of antifungal therapy
12. Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole
13. Laboratory evaluation of antifungal agents: A comparative study of five imidazole derivatives of clinical importance
14. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro
15. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates
16. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
17. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870
18. Antifungal susceptibility testing: Current state of technology, limitations, and standardization
19. Fluorescence microscopy methods for yeast
20. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
21. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing clinical isolates in a murine model of invasive candidiasis
22. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections
23. Antifungal susceptibility testing
24. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates
25. Antifungal drug resistance in pathogenic fungi
26. Candida, Cryptococcus, and other yeasts of medical importance